(VIANEWS) – NEOEN (NEOEN.PA), VERALLIA (VRLA.PA), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NEOEN (NEOEN.PA)
48.5% sales growth and 7.39% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France. Neoen S.A. operates as a subsidiary of Impala SAS.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €1.14.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 24.32. Meaning, the purchaser of the share is investing €24.32 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.6%, now sitting on 556.1M for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 0.5%.
Moving Average
NEOEN’s value is higher than its 50-day moving average of €26.87 and under its 200-day moving average of €29.25.
More news about NEOEN.
2. VERALLIA (VRLA.PA)
19.7% sales growth and 44.03% return on equity
Verallia Société Anonyme produces and sells glass packaging products for beverages and food industry worldwide. It also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. The company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. Verallia Société Anonyme was founded in 1827 and is based in Courbevoie, France.
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.08.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 10.29. Meaning, the purchaser of the share is investing €10.29 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.03%.
Sales Growth
VERALLIA’s sales growth is 27.9% for the ongoing quarter and 19.7% for the next.
Moving Average
VERALLIA’s worth is higher than its 50-day moving average of €39.02 and way higher than its 200-day moving average of €36.72.
More news about VERALLIA.
3. NAVAMEDIC (NAVA.OL)
17.3% sales growth and 10.19% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 31.69. Meaning, the purchaser of the share is investing kr31.69 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.19%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.40 at 17:20 EST, way under its 52-week high of kr43.90 and way above its 52-week low of kr31.00.
Sales Growth
NAVAMEDIC’s sales growth is 22.8% for the ongoing quarter and 17.3% for the next.
More news about NAVAMEDIC.
4. ITERA (ITERA.OL)
12.4% sales growth and 97.07% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.79.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 14.3. Meaning, the purchaser of the share is investing kr14.3 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 97.07%.
Sales Growth
ITERA’s sales growth is 11.8% for the ongoing quarter and 12.4% for the next.
Yearly Top and Bottom Value
ITERA’s stock is valued at kr11.30 at 17:20 EST, below its 52-week low of kr11.45.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ITERA’s EBITDA is 41.68.
More news about ITERA.
5. DNB BANK (DNB.OL)
12% sales growth and 15.02% return on equity
DNB Bank ASA provides financial services for retail and corporate customers in Norway and internationally. The company offers personal banking products and services, including savings and investment products; loans, such as home mortgages, and car and consumer loans; pet, home and property, travel, and personal insurance products, as well as insurance products for vehicles; retirement savings products; foreign exchange and treasury activities; and Internet and mobile banking services, as well as cards. It also provides business banking products and services comprising savings and investment products consisting of savings accounts, fixed rate deposits, exchange traded products, bonds and commercial papers, asset management, and equity services; financing, such as installment loans, overdraft facility, bank guarantees, leasing, factoring, and trade and export financing services; transaction banking services; research, commodities, bonds and commercial papers, corporate finance, debt capital market, equities, foreign exchange and interest rates, and securities services; and Internet services, including online equity trading, online FX trading, e-confirmation, equities execution, and investor and margin accounts, as well as pension services. In addition, the company provides investment banking services, such as mergers and acquisition, and equity and debt capital market services; foreign exchange, interest rates, equities, commodities, fixed income, research, private equity, and securities services; and corporate banking services. Further, it offers private banking services. The company offers its products and services to various sectors, including energy; financial institutions; healthcare; manufacturing; packaging and forest products; seafood; shipping, offshore, and logistics; and telecom, media, and technology. DNB Bank ASA was founded in 1822 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, DNB BANK has a trailing twelve months EPS of kr24.81.
PE Ratio
DNB BANK has a trailing twelve months price to earnings ratio of 8.14. Meaning, the purchaser of the share is investing kr8.14 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.
Volume
Today’s last reported volume for DNB BANK is 765007 which is 51.39% below its average volume of 1573850.
Sales Growth
DNB BANK’s sales growth is 24.3% for the present quarter and 12% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 16.6%, now sitting on 74.07B for the twelve trailing months.
More news about DNB BANK.
6. SPAREBANKEN MØRE (MORG.OL)
6% sales growth and 11.3% return on equity
Sparebanken Møre, together with its subsidiaries, provides banking services for retail and corporate customers in Norway. It operates through Retail and Real Estate Brokerage segments. The company offers services in the areas of financing, deposits and other forms of investments, payment transfers, financial advisory services, asset management, insurance, and real estate brokerage. Sparebanken Møre was founded in 1843 and is headquartered in Ålesund, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN MØRE has a trailing twelve months EPS of kr16.2.
PE Ratio
SPAREBANKEN MØRE has a trailing twelve months price to earnings ratio of 4.72. Meaning, the purchaser of the share is investing kr4.72 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.3%.
Moving Average
SPAREBANKEN MØRE’s value is below its 50-day moving average of kr77.49 and under its 200-day moving average of kr78.51.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 5.23%.
Yearly Top and Bottom Value
SPAREBANKEN MØRE’s stock is valued at kr76.54 at 17:20 EST, way under its 52-week high of kr88.88 and above its 52-week low of kr71.31.
Volume
Today’s last reported volume for SPAREBANKEN MØRE is 8138 which is 52.04% below its average volume of 16970.
More news about SPAREBANKEN MØRE.
